Buy Klacid (Clarithromycin) tablets extended release 500 mg

Klacid (Clarithromycin) tablets extended release 500 mg

23945USD

Description

Features

Reviews

Instructions for Klacid (Clarithromycin) tablets extended release

English product name
Klacid® SR

Release Form
tab. with prolong release film sheath, 500 mg: 5, 7, 10, 14 or 28 pcs.

Description antimicrobial Klacid
Prolonged release pills coated with yellow film sheath oval.

1 tab.
clarithromycin 500 mg
Auxiliary substances: citric acid anhydrous - 128 mg, sodium alginate - 120 mg, sodium alginate - 15 mg, lactose monohydrate - 115 mg, Povidone K30 - 30 mg, talc - 30 mg, stearic acid - 21 mg, magnesium stearate - 10 mg.

The film sheath consists of 9.81 mg of hypromellose, 400 - 3.27 mg of macrogol, 8,000 - 3.27 mg of macrogol, 1.64 mg of titanium dioxide, 1.23 mg of dye yellow (quinoline yellow) and 0.16 mg of sorbic acid.

ATC codes
J01FA09 Clarithromycin

Clinical-pharmacological groups / Group affiliation
Macrolide group

Active substance
clarithromycin

Pharmaco-therapeutic group

macrolide, antimicrobial

Storage Conditions
The drug should be stored in a place inaccessible to children, protected from light at a temperature not higher than 25 ° C.

Best before date
The shelf life is 3 years. Do not apply after expiry date.

Pharmacological effect Klacid

A semi-synthetic of the macrolide group. Clarithromycin has an antibacterial effect by interacting with the 50S ribosomal subunit and inhibiting the protein synthesis of bacteria sensitive to it.

Testimony Klacid

Infectious inflammatory diseases caused by clarithromycin-sensitive microorganisms:
lower respiratory tract infections (such as bronchitis, pneumonia);
upper respiratory tract infections (such as pharyngitis, sinusitis);
Skin and soft tissue infections (such as folliculitis, subcutaneous inflammation, and rye).

Method of use, course and dosage Klacid

The drug antimicrobial is taken inside. Tablets should not be broken and chewed, they should be swallowed whole.
Adults and children over the age of twelve are given one tab (five hundred mg) once a day during meals. For severe infections, the dose is increased to two tabas (1000 mg) once a day during meals.
The duration of treatment is usually between five and fourteen days. The exceptions are out-of-hospital pneumonia and sinusitis, which require treatment for six to fourteen days.
In patients with severe renal insufficiency (QC less than thirty ml/min), the recommended dose is two hundred and fifty mg once a day, in which case Clacid® in the form of a film-coated tablet, two hundred and fifty mg is possible. For more severe infections, the recommended dose is one tablet. five hundred mg with prolonged release of clarithromycin. In patients with moderate-stage renal failure (MMR between thirty and six ten ml/min), no dose correction is required.